Prescribing Influences: Alzheimer's Disease - Alleviating symptoms remains the goal for prescribersDatamonitor
June 13, 2011
45 Pages - SKU: DFMN6424851
More Alzheimer's Disease reports by Datamonitor
Market and Product Forecasts: Alzheimer's Disease – Multi-billion dollar potential in high-risk pipeline by Datamonitor
IntroductionThe Alzheimer’s disease market across the seven major markets is set to double in value over the next 10 years, from $5.3bn in 2011 to ...
Product Profiles: Alzheimer's Disease - Amyloid setbacks prolong wait for disease modification by Datamonitor
IntroductionThe beta-amyloid hypothesis has so far failed to deliver a viable candidate, contributing to an absence of new market entrants over the past decade. However, ...
Product Profiles: Alzheimer's Disease by Datamonitor
The beta-amyloid hypothesis has so far failed to deliver a viable candidate, contributing to an absence of new market entrants over the past decade. However, ...
Market and Product Forecasts: Top 10 Neurology Brands 2011–21 by DatamonitorSee all reports like this >>
The diverse field of neurology hosts numerous disorders with substantial unmet clinical need, creating a complex but lucrative market. Considerable rewards are available for the ...
We can help you find what you need. Call us or write us:
Need help in your search?
Alzheimer's Disease Reports
- Immunoglobulins Market to 2019 - Demand in Primary Immunodeficiency (PI) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Potentially Supplemented by Approvals for Alzheimer’s Disease
- Alzheimer Disease Treatment Drugs Markets in China
- Dementia Associated With Alzheimer's Disease – Pipeline Review, H1 2013
- Alzheimer's Disease – Pipeline Review, H1 2013
- EpiCast Report: Alzheimer’s Disease - Epidemiology Forecast to 2022